Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06170983
NA
Skin Inflammation and PK of Azithromycin
Sponsor: Medical University of Vienna
View on ClinicalTrials.gov
Summary
This study will investigate the tissue distribution of azithromycin in healthy, artificially inflamed and actually infected tissue of humans.
Official title: Validation of Imiquimod- and LPS-induced Skin Inflammation Models and Their Application in the Investigation of Azithromycin Concentration in Inflamed, Infected, and Healthy Subcutaneous Tissue
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2024-01-01
Completion Date
2026-07-01
Last Updated
2023-12-14
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Azithromycin
500 mg once daily for 3 days
DIAGNOSTIC_TEST
Biopsy
Skin punch biopsy
OTHER
Skin inflammation model
LPS- or imiquimod induced skin inflammation